Topaloglu, H. 2021. Expensive molecular therapies for rare genetic disorders: carrier detection or newborn screening should be the strategy. A personal opinion. Journal of the International Child Neurology Association. 1, 1 (Dec. 2021). DOI:https://doi.org/10.17724/jicna.2021.225.